Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Serra

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Molecular Cancer Therapeutics|July 29, 2016
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant OsteosarcomaIlaria Buondonno, Elena Gazzano, Sae Rin Jean, et al.
Cancer Letters|May 4, 2019
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenograftsElena Gazzano, Ilaria Buondonno, Alessandro Marengo, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 9, 2022
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axisMichela Pasello, Anna Maria Giudice, Camilla Cristalli, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 23, 2022
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axisMichela Pasello, Anna Maria Giudice, Camilla Cristalli, et al.
European Journal of Medicinal Chemistry|March 30, 2023
Targeting the multifaceted neurotoxicity of Alzheimer's disease by tailored functionalisation of the curcumin scaffoldErsilia De Lorenzi, Francesca Seghetti, Andrea Tarozzi, et al.
International Journal of Molecular Sciences|April 28, 2023
Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical NeedSilvia Vanni, Valentina Fausti, Eugenio Fonzi, et al.
BMC Cancer|May 22, 2013
IR/IGF1R signaling as potential target for treatment of high-grade osteosarcomaMarieke L Kuijjer, Elisabeth F P Peterse, Brendy E W M van den Akker, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 ProtocolJuliana Salazar, María J Arranz, Javier Martin-Broto, et al.
Oncogene|April 12, 2002
Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21Leonardo A Meza-Zepeda, Anne Forus, Birgitte Lygren, et al.
International Journal of Molecular Sciences|November 13, 2025
Establishment and Characterization of OS-MET-R-092: A Novel Patient-Derived Cell Culture from an Osteosarcoma Bone MetastasisVeronica Giusti, Leonardo Fantoni, Monica Torsello, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Molecular Cancer Therapeutics|July 29, 2016
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant OsteosarcomaIlaria Buondonno, Elena Gazzano, Sae Rin Jean, et al.
Cancer Letters|May 4, 2019
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenograftsElena Gazzano, Ilaria Buondonno, Alessandro Marengo, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 9, 2022
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axisMichela Pasello, Anna Maria Giudice, Camilla Cristalli, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 23, 2022
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axisMichela Pasello, Anna Maria Giudice, Camilla Cristalli, et al.
European Journal of Medicinal Chemistry|March 30, 2023
Targeting the multifaceted neurotoxicity of Alzheimer's disease by tailored functionalisation of the curcumin scaffoldErsilia De Lorenzi, Francesca Seghetti, Andrea Tarozzi, et al.
International Journal of Molecular Sciences|April 28, 2023
Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical NeedSilvia Vanni, Valentina Fausti, Eugenio Fonzi, et al.
BMC Cancer|May 22, 2013
IR/IGF1R signaling as potential target for treatment of high-grade osteosarcomaMarieke L Kuijjer, Elisabeth F P Peterse, Brendy E W M van den Akker, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 ProtocolJuliana Salazar, María J Arranz, Javier Martin-Broto, et al.
Oncogene|April 12, 2002
Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21Leonardo A Meza-Zepeda, Anne Forus, Birgitte Lygren, et al.
International Journal of Molecular Sciences|November 13, 2025
Establishment and Characterization of OS-MET-R-092: A Novel Patient-Derived Cell Culture from an Osteosarcoma Bone MetastasisVeronica Giusti, Leonardo Fantoni, Monica Torsello, et al.
Pageof 16